Articles From: Camtek Announces Third Quarter 2014 Results to Canacol Energy Ltd. Announces Strategic Financing With Apollo Investment Corporation


2014/10/29
$22.4 million revenue; $1.1 million operating income on a non-GAAP basis; Gryphon demonstration center launched in Southern California MIGDAL HAEMEK, Israel , Oct.
Sign-up for Camtek Announces Third Quarter 2014 Results investment picks
2015/1/5
MIGDAL HA'EMEK, Israel , January 5, 2015 /PRNewswire/ -- Camtek Ltd.
Sign-up for Camtek to Present at the 17th Annual Needham Growth Conference in New York investment picks
2014/11/20
MIGDAL HA'EMEK, Israel , November 20, 2014 /PRNewswire/ -- Camtek Ltd.
Sign-up for Camtek to Present at the LD Micro Conference and Host Investors at its Gryphon Demonstration Center investment picks
2014/12/9
Initial orders received total $2.8 million; the systems will be used for Advanced Packaging applications MIGDAL HAEMEK, Israel , December 9, 2014 /PRNewswire/ -- Camtek Ltd.
Sign-up for Camtek Wins Head-to-Head Competition to be Supplier of Choice for AOI Systems at Leading Semiconductor Manufacturer investment picks
MIGDAL HA'EMEK, Israel , November 25, 2014 /PRNewswire/ -- Camtek Ltd.
Sign-up for Camtek's 3D Functional InkJet Technology System, Gryphon, Successfully Concludes a Beta-Test investment picks
2014/12/31
By Brett Arends, MarketWatch An energy glut threatens an auto industry success story Everybody loves Tesla Motors.
Sign-up for Can Tesla survive collapsing gas prices? investment picks
2014/12/2
PETACH TIKVA, Israel , Dec.
Sign-up for Can-Fite Announces $8 Million At-The-Market Registered Direct Offering investment picks
PETACH TIKVA, Israel, Nov.
Sign-up for Can-Fite Announces Special General Meeting of Shareholders to Elect External Director investment picks
PETACH TIKVA, Israel , Jan.
Sign-up for Can-Fite Announces Upcoming 2015 Clinical Milestones for its Pipeline of Drugs in 4 Indications investment picks
The estimated global market of Rheumatoid Arthritis is expected to reach $38B in 2017 PETACH TIKVA, Israel , Dec.
Sign-up for Can-Fite Completes the Design of the Rheumatoid Arthritis Phase III Study of Its Lead Drug Candidate CF101 investment picks
Trial follows successful Phase I/II study which met all study endpoints CF102 granted Orphan Drug Status for this indication by the FDA Global Industry Analysts predict that the global market for liver cancer is projected to exceed $2B by 2015 PETACH TIKVA, Israel , Dec.
Sign-up for Can-Fite Doses First Patient in Global Phase II Liver Cancer Trial for CF102 investment picks
PETACH TIKVA, Israel , Nov.
Sign-up for Can-Fite Near-Term Milestones Timetable for 2014/2015 investment picks
PETACH TIKVA, Israel , Dec.
Sign-up for Can-Fite Reports Financial Results for Nine Months Ended September 30, 2014 investment picks
CF602 is Efficacious in Improving Sexual Dysfunction in Proof of Concept studies; Targeting a Multi-Billion Market PETACH TIKVA, Israel , Dec.
Sign-up for Can-Fite to Initiate the Development Program of its Next Generation Drug CF602 investment picks
Europe's largest partnering conference for the global biotechnology industry PETACH TIKVA, Israel , Oct.
Sign-up for Can-Fite to Participate in BIO-Europe International Partnering Conference investment picks
2014/11/5
Dennis Miller joins Board of Directors of Canaccord Genuity Group Inc. TORONTO , Nov.
Sign-up for Canaccord Genuity Group Inc. appoints new independent director investment picks
2014/12/29
Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme Canada NewsWire TORONTO , Dec.
Sign-up for Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme investment picks
2014/12/22
Canaccord Genuity Group Inc. discloses transaction in own shares under Normal Course Issuer Bid/buy-back programme Canada NewsWire TORONTO , Dec.
Sign-up for Canaccord Genuity Group Inc. discloses transaction in own shares under Normal Course Issuer Bid/buy-back programme investment picks
2015/1/12
Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme Canada NewsWire TORONTO , Jan.
Sign-up for Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme investment picks
2015/1/19
Canaccord Genuity Group Inc. Discloses Transaction In Own Shares Under Normal Course Issuer Bid/Buy-Back Programme Canada NewsWire TORONTO , Jan.
Sign-up for Canaccord Genuity Group Inc. Discloses Transaction In Own Shares Under Normal Course Issuer Bid/Buy-Back Programme investment picks
2015/1/2
Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme and total voting rights Canada NewsWire TORONTO , Jan.
Sign-up for Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme and total voting rights investment picks
2015/1/5
Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme, cancellation of shares and total voting rights Canada NewsWire TORONTO , Jan.
Sign-up for Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme, cancellation of shares and total voting rights investment picks
2014/11/5
Excluding significant items, second quarter diluted earnings per share of $0.17 (1) compared to $0.03 (1) one year ago (All dollar amounts are stated in Canadian dollars unless otherwise indicated) TORONTO , Nov.
Sign-up for Canaccord Genuity Group Inc. reports second quarter fiscal 2015 results and adjusted net income improvement of 208% investment picks
Canaccord Genuity analyst Michael Walkley on Tuesday raised his price target on Apple Inc.'s (AAPL) stock to $135 a share from $120. Walkley said that smartphone surveys for November "indicated very strong demand for the iPhone 6 and 6 Plus smartphones." Walkley added that while Apple has had some issues meeting demand for the 64-gigabyte versions of the new iPhones, he still believes Apple will ship 63 million iPhones during the first quarter of its 2015 fiscal year.
Sign-up for Canaccord ups Apple price target to $135 a share investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0984970001&sourceType=1 http://www.ccnmatthews.com/logos/20100823-cnelogo.jpg CALGARY, ALBERTA --
Sign-up for Canacol Announces Acquisition of VIM 5 and VIM 19 E&P Contracts and Clarinete Gas Discovery in the Lower Magdalena Valley of Colombia investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0980805001&sourceType=1 http://www.ccnmatthews.com/logos/20100823-cnelogo.jpg CALGARY, ALBERTA --
Sign-up for Canacol Energy Ltd. Announces Meeting Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976000001&sourceType=1 http://www.ccnmatthews.com/logos/20100823-cnelogo.jpg CALGARY, ALBERTA --
Sign-up for Canacol Energy Ltd. Announces Strategic Financing With Apollo Investment Corporation investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Camtek Announces Third Quarter 2014 Results to Canacol Energy Ltd. Announces Strategic Financing With Apollo Investment Corporation
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent